Related Experiment Videos
Future promises revolutionary change for medicine
1Anticipatory Sciences Incorporated, St. Paul, Minnesota.
Minnesota Medicine
|January 1, 1993
Summary
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Arterial lesions induced by phosphodiesterase III (PDE III) inhibitors and DA(1) agonists.
Toxicology letters·2000
Mesalazine: an overview of key preclinical studies.
Scandinavian journal of gastroenterology. Supplement·1990
Coronary vascular lesions in dogs treated with phosphodiesterase III inhibitors.
Toxicologic pathology·1989
Vaping, lung injury, and mental health Minnesota 2018-2019.
Minnesota medicine·2021
When the world comes to us.
Minnesota medicine·2018
Laying down my stethoscope.
Minnesota medicine·2018
Sulfide Mining and Human Health in Minnesota.
Minnesota medicine·2018
The Psychiatric Assistance Line: Six-Month Follow-up on Consultations to Primary Care.
Minnesota medicine·2018
From neuraminidase inhibitors to novel mechanisms: expanding therapeutic strategies against influenza.
Frontiers in cellular and infection microbiology·2026
An Intelligent Spatially Selective Modified Starch Hydrogel Dressing Breaks the Stability-Efficiency Trade-Off in Bioactive Delivery.
Advanced healthcare materials·2026
Keratin 17 Methyltransferasean14 Methylation Axis: A Novel Mechanism in Pulmonary Vascular Remodeling.
Journal of the American Heart Association·2026
O-mannosylation and furin processing are critical maturation events for the KIAA1549 protein implicated in pediatric pilocytic astrocytomas.
The Journal of biological chemistry·2026